Pricing and Reimbursement Market Analysis

In today’s climate of cost containment and ever-changing regulations, achieving optimal pharma pricing and reimbursement remains critical, yet it has never been more challenging.

World Markets Pricing and Reimbursement is a sophisticated market analysis tool providing comprehensive, forward-looking analysis of drug pricing and reimbursement on a global scale.

Subscribers gain the competitive advantage by accessing daily news on over 25 markets and monthly in-depth reports on key trends, a unique reference pricing matrix tool covering over 30 markets, and a pharma pricing and reimbursement database of guideline differences across over 30 markets.

World Markets Pricing and Reimbursement helps you:

• Evaluate market opportunities and risks
• Monitor competitors and customers
• Make informed decisions
• Assess the impact of a changing regulatory environment
• Plan and forecast budgets
• Stay up to date with pricing and reimbursement developments and market trends

Solving your key pricing and reimbursement problems:

Same-Day Pharmaceutical Pricing and Reimbursement Analysis 

• Timely analysis of the pricing and reimbursement (P&R) environment on a global scale 
• Coverage of key topics, including: 
• Changes in P&R policies and regulations 
• Significant drug-level P&R developments 
  • Regulatory submission 
  • Marketing launch
  • Reimbursement decision 
  • Price change 
• Public health insurance reform 
• Latest official national spending and pricing trend data

Country Profiles 

• Constantly updated country profiles for 25 leading and emerging markets focusing on: 
  • Medium-term policy drivers, including demographic, political, and economic pressures 
  • P&R perspective on the pharmaceutical market's structure 
  • The detailed P&R regulatory framework, including cost containment analysis 
  • P&R policy change outlook

Special Reports 

• Monthly examination of key P&R trends across major pharmaceutical markets

Pricing and Reimbursement Policy Database

• Interactive database for comparing the impact of specific P&R policies across over 30 markets, including:
  • Reference pricing
  • Price cuts
  • Co-payments

Reference Pricing Matrix

• Unique, online tool for quick comparison and contrast of countries that use each other for international referencing policies in over 30 markets

Our expert team provides an independent, fact-based view of the healthcare and pharmaceutical industry, fully supported by our 325+ economists and analysts worldwide with expertise in over 120 industries and 200 countries.

IHS Global Insight is the world leader in economic and financial analysis, forecasting, and market intelligence—with more than 40 years' experience and an outstanding record for accuracy.